title: Treatment of relapsed and refractory acute myeloid leukemia in adults.
authors.affiliation: Division of Hematology, IRCCS Policlinico S. Matteo, Pavia, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Lazzarino
authors.forename: E
authors.initials: E
authors.lastname: Morra
authors.forename: E P
authors.initials: EP
authors.lastname: Alessandrino
authors.forename: S
authors.initials: S
authors.lastname: Merante
authors.forename: P
authors.initials: P
authors.lastname: Bernasconi
authors.forename: M
authors.initials: M
authors.lastname: Bonfichi
authors.forename: D
authors.initials: D
authors.lastname: Caldera
authors.forename: C
authors.initials: C
authors.lastname: Bernasconi
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D004351:Drug Resistance; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D003561:Cytarabine; D005047:Etoposide; D008942:Mitoxantrone; D015255:Idarubicin